Background: ATP-binding Cassette (ABC) transporters have key roles in various physiological functions as well as providing chemical defense and stress tolerance in human tissues. In this study we have examined the expression pattern of all ABC proteins in pluripotent human embryonic stem cells (hESCs) and in their differentiated progenies. We paid special attention to the cellular expression and localization of multidrug transporter ABC proteins.
Introduction
The ABC protein family is present from bacteria to humans, and the 48 human ABC proteins include several transporters, channels, as well as non-membrane proteins (1) . During the past decades a large amount of information became available about the expression and function of these human proteins, while there are still numerous unresolved questions in this field. We have shortly summarized the recent knowledge about the human ABC proteins in
Supplementary Table 1.
Certain ABC transporters form a special network of chemo-defense system, as these ATP-dependent active transporters extrude a wide variety of substrates from the cells, including endo-and xenobiotics. While these ABC transporter (with a key role of ABCB1/Pgp, ABCC1/MRP1 and ABCG2/BCRP) proteins play an important role in protecting our body, they are also involved in causing multidrug resistance in cancer cells (2, 3) . One member of these multidrug transporters, ABCG2, has been shown to play a major role in the protection of stem cells against toxic compounds. In addition, the ABCB6 protein has been indicated to play a major role in the defense against toxic heme derivatives, while the ABCA1 protein has a key role in the extrusion of excess cellular lipid derivatives, especially cholesterol (see refs (4) (5) (6) (7) (8) (9) ).
Since the human embryonic stem cells (hESC) require special protection during development, and some of the differentiated tissues are also well protected against toxic agents, an important task is to follow the changes in the expression and localization of the ABC multidrug transporters during these early developmental processes.
In our previous studies we have shown that the HUES9 embryonic stem cells express the ABCG2 protein at the cell surface (10) , and this transporter has an important role in defending the HUES9 cells during stress conditions (5) . In the current work we have examined the full pattern of 48 human ABC protein mRNA expression levels by qPCR-based microarray, in order to provide information about changes in their tissue expression patterns in undifferentiated and selectively differentiated hES cells. We have also followed the expression of selected ABC transporter proteins by flow cytometry and immunostaining during early human cell differentiation. In addition to provide basic information about ABC protein expression, these studies also allowed to examine the cellular localization of these transporter proteins which was not exactly known for embryonic stem cells and their derivates. 
Materials and Methods

Cell culture and differentiation
The hES cell line HUES9 (originally provided by Dr. Douglas Melton, Harvard University) were maintained on mitotically inactivated mouse embryonic fibroblasts (MEF) and spontaneous differentiation were performed via embryoid body (EB) formation as described previously (11) . After 6 days embryoid bodies were placed onto gelatin coated 24 well plates, where they attached to the surface and underwent spontaneous differentiation. The desired cell types were separated as follows:
Some of the EB-outgrowths start spontaneously beating within a few days post-plating.
These rhythmically contracting areas were isolated mechanically and hES cell-derived cardiomyocytes were re-plated on gelatin coated 8 well confocal chambers or harvested to RNA isolation. Neuronal progenitor cells with rosette-like morphology were mechanically isolated for generation of hES cell-derived neural cells, between days 8 and 10. These rosettes were able to re-attach onto gelatin coated surfaces and continue their further differentiation to mature neural cell types. The RNA isolation and immunostaining were performed at day 24.
The mesenchymal stem cell like (MSCl) cells were generated and maintained as described previously (12) . For more details see the Supplementary Methods.
Flow cytometry
Single cell suspensions were prepared by gentle trypsinization, and the cells were labeled in PBS containing 0.5% bovine serum albumin with appropriate antibodies. In all hESC samples an anti-mouse Sca-1 (Ly-6A/E) (FITC or PE, BD Pharmingen) antibody was employed for gating out the positively labeled mouse feeder cells.
We used the following directly labeled anti-human antibodies: SSEA4-APC and PODXL-PE (R&D Systems) for investigation of pluripotency. For indirect staining of ABC transporters the following monoclonal antibodies were applied: 5D3 (BD Pharmingen) for ABCG2, MRK16 (Alexis Biochemicals) for ABCB1, anti-Lan (OSK43 (generated and kindly provided by Hideo Takahashi Japanese Red Cross Osaka Blood Center, Japan) (13)) for ABCB6, R1 (Abcam) for ABCC1 and AB H10 (Abcam) for ABCA1 labeling. The 5D3 labeling was performed in the presence of Ko143, a specific inhibitor of ABCG2, which maximizes 5D3 binding (14) . Control staining with appropriate isotype-matched control mAbs was included. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w 
Immuno-cytochemical staining
Immunostaining of all cell types was performed as described previously (10) , except the cell surface labeling of ABCG2 which was carried out as described by (5) . For labeling of pluripotent and differentiation markers the following primary antibodies were applied: Oct4 (SantaCruz), Nanog, SSEA4 and PODXL (RnD Systems) cardiac Troponin-I (Sigma), Nestin (Abcam), β-III Tubulin (RnD Systems) and CD-44-FITC (BD Pharmigen). The ABC transporters were studied by the same antibodies used for flow cytometry. Hoechst33342 (Invitrogen) was used for nuclear staining. The stained samples were examined by an Olympus FV500-IX confocal laser scanning microscope. For more details see the Supplementary Methods.
Gene expression analysis
Total RNA was isolated from the cells using the Trizol reagent (Life Technologies). RNA integrity was checked by standard gel electrophoresis, RNA concentration was determined by spectrophotometry using a NanoDrop 2000 Spectrophotometer (Thermo Scientific). Gene 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Results
Differentiation of hES cells -characterization by differentiation markers
For studying the expression of human ABC proteins in pluripotent cells and in their differentiated derivatives, we have generated cardiac cells, mesenchymal-like stem cells (MSCls (12) ) and neural cells from the HUES9 cells, by using a method of spontaneous differentiation, via EB formation (Supplementary Fig. 1 ). With this method the desired cell types could be generated from hESC without the addition of special chemicals, and the selection of the differentiated progenies was performed by enzymatic digestion and/or mechanical selection, without applying any drug selection or cell sorting. All the differentiated cell types were cultured in the same media and under similar conditions (see Materials and Methods). These uniform conditions were used because the expression levels and localization of several ABC proteins have been shown to be influenced by chemical inducers, selection drugs or antibiotics (see ref. (15, 16) ).
When selecting various tissue types, we performed a detailed phenotypic characterization of the parental and differentiated cell types, in order to assure that any further analysis should be performed by using properly selected populations. This characterization included the investigation of several cell type specific markers by flow-cytometry and immunocytochemistry.
As shown in Figure 1A , by flow cytometry studies we found that the pluripotent hES cells (HUES9) highly expressed the SSEA-4 and PODXL pluripotency markers on the cell surface. Using immunostaining and confocal microscopy, we could clearly show the presence of the nuclear pluripotency markers, Oct4 and Nanog, as well as the cellular membrane staining of SSEA-4 and PODXL (Fig. 1B) .
During differentiation studies, cell surface markers for MSCls were analyzed as described in detail in our previous work (see (12) ). In all cases, immunostaining revealed Fig. 2A) , showing relative gene expression levels. The cluster analysis (see Methods), documented in Fig. 2B , shows close correlation of the mRNA expression pattern with the differentiation status of the cell samples.
As shown, the biological parallels (for hESC and MSCl) clustered together, while the undifferentiated hESC samples are clearly separated from the partially differentiated sample (6 days EB). The mRNA clusters of the differentiated cell types are noticeably different from that of the hESCs and from one another and the biological replicates of the most differentiated cell types (the MSCl cells, after 80 days of differentiation) are located away from the undifferentiated cells with the longest distance in the dendrogram. As shown by the highest expression levels found in the pluripotency array data, the hES cells showed high levels of the pluripotency mRNA markers, while the derivative cells showed upregulated levels of the proper lineage-specific markers (Fig 2C) .
ABC transporter expression in pluripotent and differentiated hES cells -flow cytometry studies
In these experiments we investigated the ABC transporter expression in the pluripotent and differentiated cells at the protein level. The application of specific and properly reactive antibodies is a crucial question in these experiments. Especially in the case of the flow cytometry studies, we used antibodies against extracellular epitopes to examine the expression and cell surface localization of ABCG2 (mAb 5D3), ABCB1 (mAb MRK16), and ABCB6 (mAb OSK43). However, most of the antibodies recognizing human ABC transporters have been generated against intracellular epitopes, and in several experiments we have used such antibodies (see Methods). In each case, the specific protein recognition was assured by examining various cell types overexpressing these ABC transporters (suppl. fig 2a) .
The two major cell types in which ABC transporter expression could be studied without major cellular damage were the undifferentiated hES cells and the MSCs. In these cell types we focused on the expression of ABC multidrug or lipid transporters with key roles in cellular chemodefense and stress response. As shown in Fig. 3 , in the case of ABCB1, ABCB6 and ABCG2 we used the respective antibodies recognizing extracellular epitopes, while in the case of ABCC1 and ABCA1 we employed antibodies generated against intracellular protein domains. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In this case the expression levels of all studied transporters were negligible without permeabilization (Fig 4 A) , but were well detectable in the permeabilized cells in the case of ABCB6, ABCC1, and especially of ABCA1. It is important to note that ABCG2 expression was not detectable in these cells, with or without permeabilization.
In the case of ABCB1 and ABCB6 (antibodies reacting with external membrane epitopes) the potential expression of these proteins in intracellular membrane compartments may be suggested by these data. Since the ABCC1 and ABCA1 antibodies recognize intracellular epitopes, the increased protein levels found in the permeabilized cells most probably correspond to increased general expression levels, and in this case the plasma membrane or intracellular membrane expression levels cannot be distinguished. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 protein, as this transporter has been indicated to play an important role in cardiac tissues (17, 18) . However, we could not detect ABCC6 expression in any of the examined hESCderived cell types.
ABC transporter expression in pluripotent and differentiated hES cellsimmunomicroscopy studies
ABC protein mRNA expression in pluripotent and differentiated hES cells
Because of the lack of reliable antibodies and staining protocols for numerous human ABC proteins, a systematic analysis can only be performed for the respective mRNA expression levels. For this purpose we used a quantitative RT-PCR technology and ABC protein specific microarray, and examined the same mRNA samples as used in the pluripotency array analysis (see Fig. 2 ), obtained from pluripotent hESCs and the differentiated cell types. A visual overview of these gene expression data is demonstrated in a heat-map (Fig. 6 A) , while the original Ct data are presented in the Supplementary Table 3 .
When analyzing the ABC mRNA array we observed that the expression of ABC transporters in general showed lower mRNA expression levels than the pluripotency markers (average Ct (ABC) = 33,6 ± 2,8; average Ct (pluri) = 21,6 ± 7,6), as compared to the similar level measured for the expression of the housekeeping genes. Since membrane protein expression usually requires long term expression of relatively smaller amount of proteins, this result was in accordance with our expectations. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Remarkably, clustering based on ABC transporter profiles was found to be similar to the hierarchy defined by pluripotency markers (see Fig. 2 ), indicating that all the examined cell types have characteristic expression patterns (fingerprints) for the ABC proteins, depending on the cell maturation status. As shown in Fig 6C, some of the ABC proteins showed similar (medium) level of expression in all cell types (Fig 6C left panel) , although most of these ABC proteins are not well described transporters, and some are not even membrane proteins (see Suppl. table 1). These data suggest a role of these ABC proteins in the general maintenance of cellular homeostasis.
In the following analysis, we focused on the recognized ABC membrane transporters, and excluded those proteins which showed high Ct values, indicating extremely low or no expression (Fig 6C right panel) . We compared the relative expression of ABC transporter mRNAs in differentiated cells to those in undifferentiated hES cells (Supplementary table
4).
As shown in Fig7 and presented in supplementary table 4, we found that most of the ABC transporters were expressed at significantly higher level (although in different magnitudes, see Fig 7A and B) in the differentiated cell types than in the pluripotent hESCs.
When analyzing the cell-type dependent expression, we found that several ABC transporter mRNA levels showed large increase in differentiated progenies. These included the expression of ABCA8, ABCC3, ABCC9, and ABCG1. In contrast, there were several transporter mRNA expression levels characteristic for certain cell types: changes of ABCB1 and ABCC6 expressions were higher in cardiac cells and ABCA4 was higher in neural cells compared to hESC (Fig 7A) . Note, that the only ABC transporter which showed a decreased expression level in all differentiated cell types was ABCG2 (Fig 7B) .
This cell type-specific expression indicates a possible role of these proteins in the differentiated tissues and allows a further characterization of their physiological roles. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In these experiments first we examined pluripotency and tissue-specific marker protein expression in the selected cell types by flow cytometry and immunostaining. We have also carried out the investigation of the mRNA expression pattern of a wide range of pluripotency and differentiation markers by using RT-PCR based quantitative arrays. These studies established a proper characterization of the respective cell types.
When looking for ABC protein expression, we found that the mRNA expression levels of all the 48 human ABC proteins also clearly distinguished the pluripotent and the respective differentiated cell types. According to recent studies, distinct ABC protein patterns were observed when hESCs (HES2 and HES3) were compared to hematopoietic stem cells, unrestricted somatic stem cells and mesenchymal stem cells (19) . It has also been shown that mRNA expression levels are different in hESCs and hESC-derived hMSCs (20). However none of these studies have investigated the ABC transporter expression at protein level. In order to perform a detailed characterization, we selected several key ABC transporters involved in multidrug resistance, providing defense against stress conditions, and modulating cellular lipid metabolism. These transporters were examined by using well characterized 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In the human ES-derived neural cells we observed high level expression for ABCB6 and ABCC1, and in certain cell regions for that of ABCA1 and ABCB1. In the cardiomyocytes high level expression of ABCB6 and lower levels for ABCB1 and ABCA1 were observed.
Interestingly, certain cells in the external regions of cardiac and neural tissue samples also showed ABCG2 expression. In the MSCs a predominant, but mostly intracellular expression was observed for ABCA1, ABCB6 and ABCC1, while there was no measurable expression for ABCB1 or ABCG2. As of note, we did not find any significant ABCC6 expression at protein level in any of the cell types examined here.
As a summary, these studies may provide important information for a selective ABC protein expression pattern in human stem cells and in their differentiated offsprings. However, further studies are needed for the establishment of specialized inter-tissue and inter-organ distribution, as well as for the cellular functions of the key human ABC transporters during early human development. 
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No competing financial interests exist. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 HUES 9 cells were grown on MEF feeder cells for two days in eight-well chambers and HUES9-derived cell types were differentiated as described in Materials and Methods and were transferred mechanically into eight-well chambers for confocal microscopy. The samples were stained with specific antibodies to visualize ABCA1, ABCB1, ABCB6, ABCC1, ABCG2 and ABCC6 proteins (red) as described in the "Materials and methods" section. Nuclei were counterstained with Hoechst33342 (blue). Stained samples were examined by an Olympus FV500-IX confocal laser scanning microscope. Non-viable cells were excluded by 7AAD staining. Monoclonal antibodies specific for ABCB1, ABCB6, ABCG2, ABCC1 and ABCA1 were used to detect transporter expression as described in Materials and Methods. R1: cell population with marker positivity was gated based on the relevant isotype-matched control mAbs (B)The positive cell types were passaged into eight-well chambers for confocal microscopy.
The samples were stained with specific antibodies to visualize ABCA1, ABCB1, ABCB6, ABCC1, ABCG2 and ABCC6 proteins (green) as described in the "Materials and methods" 
Differentiation of Human Embryonic Stem Cells (HUES9)
Spontaneous differentiation of the HUES9 cells was performed via embryoid body (EB) formation system in suspension. Undifferentiated cells were passaged enzymatically with collagenase-IV and were transferred to Poly-2 Hydroxyethyl-methacrylate (Sigma-Aldrich) treated Petri dishes; therefore the spontaneous aggregation of cells and embryoid body formation could be obtained. EBs were cultured in differentiation medium consisting of Ko DMEM supplemented with 20% non heat inactivated fetal bovine serum, 1% nonessential amino acids, 1mML-glutamine, and 0.1mM beta-mercaptoethanol (Invitrogen) for six days, medium was changed daily. In case of neuronal differentiation, similarly to undifferentiated cell culture medium, 4 ng/ml bFGF was added to the culture media during EB formation.
After 6 days, the embryoid bodies were placed onto gelatin-coated 24-well plates, where they continued a further spontaneous differentiation process in D-MEM supplemented with 10% of fetal calf serum, 1% of L-Glutamine, medium was changed on every other day. After few 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
